186 related articles for article (PubMed ID: 9149418)
1. Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda).
Hrckova G; Velebny S
Parasitology; 1997 May; 114 ( Pt 5)():475-82. PubMed ID: 9149418
[TBL] [Abstract][Full Text] [Related]
2. Effects of free and liposomized praziquantel on worm burden and antibody response in mice infected with Mesocestoides corti tetrathyridia.
Hrckova G; Velebny S
J Helminthol; 1995 Sep; 69(3):213-21. PubMed ID: 8522765
[TBL] [Abstract][Full Text] [Related]
3. Distribution of [3H]cholesterol-labelled liposomes with or without praziquantel in mice infected with Mesocestoides corti (Cestoda) tetrathyridia.
Hrckova G; Velebny S; Giboda M
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jun; 126(2):167-74. PubMed ID: 11050688
[TBL] [Abstract][Full Text] [Related]
4. Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.
Hrckova G; Velebný S; Daxnerová Z; Solár P
Parasitology; 2006 Apr; 132(Pt 4):581-94. PubMed ID: 16556345
[TBL] [Abstract][Full Text] [Related]
5. Antibody response in mice infected with Mesocestoides vogae (syn. Mesocestoides corti) tetrathyridia after treatment with praziquantel and liposomised glucan.
Hrckova G; Velebný S; Kogan G
Parasitol Res; 2007 May; 100(6):1351-9. PubMed ID: 17252273
[TBL] [Abstract][Full Text] [Related]
6. Effects of free and liposomized praziquantel on the surface morphology and motility of Mesocestoides vogae tetrathyridia (syn. M. corti; Cestoda: Cyclophyllidea) in vitro.
Hrcková G; Velebný S; Corba J
Parasitol Res; 1998; 84(3):230-8. PubMed ID: 9521013
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of silymarin elevates the therapeutic effect of praziquantel through modulation of specific antibody profiles, Th1/Th2/Tregs cytokines and down-regulation of fibrogenesis in mice with Mesocestoides vogae (Cestoda) infection.
Hrčková G; Kubašková TM; Reiterová K; Biedermann D
Exp Parasitol; 2020 Jun; 213():107888. PubMed ID: 32259552
[TBL] [Abstract][Full Text] [Related]
8. Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C.
Ditteová G; Velebný S; Hrckova G
J Helminthol; 2003 Sep; 77(3):219-26. PubMed ID: 12895280
[TBL] [Abstract][Full Text] [Related]
9. Reduction of oxidative stress and liver injury following silymarin and praziquantel treatment in mice with Mesocestoides vogae (Cestoda) infection.
Velebný S; Hrčkova G; Königová A
Parasitol Int; 2010 Dec; 59(4):524-31. PubMed ID: 20620222
[TBL] [Abstract][Full Text] [Related]
10. Impact of treatment with praziquantel, silymarin and/or beta-glucan on pathophysiological markers of liver damage and fibrosis in mice infected with Mesocestoides vogae (Cestoda) tetrathyridia.
Velebný S; Hrckova G; Kogan G
J Helminthol; 2008 Sep; 82(3):211-9. PubMed ID: 18394210
[TBL] [Abstract][Full Text] [Related]
11. Modification of macrophage -T cell interaction during infection of mice with Mesocestoides corti (Cestoda).
Kadian SK; Dixon JB; Green JR; Carter SD; Jenkins P
Parasitology; 1994 Dec; 109 ( Pt 5)():591-7. PubMed ID: 7831095
[TBL] [Abstract][Full Text] [Related]
12. Macrophage modifying factor secreted by the tetrathyridia of Mesocestoides corti (Cestoda): monoclonal antibody to the modifying factor antagonizes its immunological activity.
Kadian SK; Dixon JB; Carter SD; Jenkins P
Parasite Immunol; 1996 Feb; 18(2):65-70. PubMed ID: 9223158
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage-mediated larvicidal activity in Echinococcus granulosus and Mesocestoides corti (Cestoda) infection in mice.
Jenkins P; Dixon JB; Rakha NK; Carter SD
Parasitology; 1990 Apr; 100 Pt 2():309-15. PubMed ID: 2140599
[TBL] [Abstract][Full Text] [Related]
14. The effects of tumour necrosis factor on host-parasite relations in murine Mesocestoides corti (Cestoda) infection.
Jenkins P; Spiers S; Dixon JB; Carter SD; May S
Parasitology; 1992 Dec; 105 ( Pt 3)():453-9. PubMed ID: 1461686
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of murine Mesocestoides corti infection by bacterial lipopolysaccharide and interferon-gamma.
Jenkins P; Dixon JB; Haywood S; Rakha NK; Carter SD
Parasitology; 1991 Feb; 102 Pt 1():125-32. PubMed ID: 1903876
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the efficacy of praziquantel-liposome against alveococcosis].
Li FR; Jiang CP; Cao HX; Wang Q
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(4):251-4. PubMed ID: 8082262
[TBL] [Abstract][Full Text] [Related]
18. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice against Mesocestoides corti by subcutaneous inoculation of living tetrathyridia.
Kazacos KR
J Parasitol; 1976 Feb; 62(1):161-3. PubMed ID: 1255371
[No Abstract] [Full Text] [Related]
20. Immunopharmacological aspects of praziquantel.
Nyazema NZ; Mutamiri FF; Mudiwa I; Chimuka A; Ndamba J
Cent Afr J Med; 1995 Sep; 41(9):284-8. PubMed ID: 8591638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
